阿司匹林加重呼吸道疾病的研究进展
Research Progress of Aspirin-Exacerbated Respiratory Disease
摘要: 阿司匹林加重呼吸道疾病(Aspirin-exacerbated respiratory disease, AERD)是耳鼻喉科比较复杂难以诊断和治疗的疾病，其特征是对任何非选择性环氧化酶抑制剂的敏感、鼻息肉、哮喘，和其他临床特征，包括慢性鼻窦炎、嗜酸性粒细胞增多、嗅觉减退等。AERD的诊断需要结合病史及阿司匹林激发试验等，临床医生经常漏诊误诊。在这篇综述中，我们探讨了这种疾病的发病机制的最新研究进展及诊断方法及其安全性。
Abstract: Aspirin-exacerbated respiratory disease (AERD) is a complex disease that is difficult to diagnose and treat in otolaryngology and is characterized by nasal polyps that are sensitive to any non-selec- tive cycoxidase inhibitors Asthma, and other clinical features, including chronic sinusitis eosino-phils Hyposmia AERD diagnosis needs such as combining with the history and aspirin excitation tests, clinical misdiagnosis and doctors often misdiagnosed. In this review, we discussed the patho-genesis of this disease and diagnosis methods and the latest research progress of security.
文章引用：安雯, 袁芳. 阿司匹林加重呼吸道疾病的研究进展[J]. 临床医学进展, 2022, 12(7): 6634-6640. https://doi.org/10.12677/ACM.2022.127958

参考文献

[1] Vorsprach, M., et al. (2019) Expression of COX-1, COX-2, 5-LOX and CysLT2 in Nasal Polyps and Bronchial Tissue of Patients with Aspirin Exacerbated Airway Disease. Allergy, Asthma & Clinical Immunology, 15, Article No. 83. [Google Scholar] [CrossRef] [PubMed]
[2] Mathur, S.K. (2019) Sinus Surgery Effects on Diagnosis and Management of Patients with AERD. The Journal of Allergy and Clinical Immunology: In Practice, 7, 1589-1590. [Google Scholar] [CrossRef] [PubMed]
[3] 何善财, 许元腾. 阿司匹林加重呼吸道疾病诊治进展[J]. 中华耳鼻咽喉头颈外科杂志, 2020, 55(11): 1091-1094.
[4] Yates, C.M., Calder, P.C. and Rainger, G. (2014) Pharma-cology and Therapeutics of Omega-3 Polyunsaturated Fatty Acids in Chronic Inflammatory Disease. Pharmacology & Therapeutics, 141, 272-282. [Google Scholar] [CrossRef] [PubMed]
[5] Buchheit, K.M., et al. (2016) Thymic Stromal Lymphopoi-etin Controls Prostaglandin D2 Generation in Patients with Aspirin-Exacerbated Respiratory Disease. Journal of Allergy and Clinical Immunology, 137, 1566-1576.e5. [Google Scholar] [CrossRef] [PubMed]
[6] Roca-Ferrer, J., et al. (2011) Reduced Expression of COXs and Production of Prostaglandin E2 in Patients with Nasal Polyps with or without Aspirin-Intolerant Asthma. Journal of Al-lergy and Clinical Immunology, 128, 66-72.e1. [Google Scholar] [CrossRef] [PubMed]
[7] Picado, C., et al. (1999) Cyclooxygenase-2 mRNA Is Downex-pressed in Nasal Polyps from Aspirin-Sensitive Asthmatics. American Journal of Respiratory and Critical Care Medi-cine, 160, 291-296. [Google Scholar] [CrossRef] [PubMed]
[8] 蔡亚玮, 刘建宏, 马宁. 花生四烯酸靶向代谢组学在炎症中的研究现状[J]. 中国临床药理学杂志, 2021, 37(19): 2721-2723+2728.
[9] Uller, L., et al. (2007) Antagonism of the Prostaglandin D2 Receptor CRTH2 Attenuates Asthma Pathology in Mouse Eosinophilic Airway Inflammation. Respir-atory Research, 8, 16. [Google Scholar] [CrossRef] [PubMed]
[10] Mullol, J., et al. (2021) Eicosanoid Dysregula-tion and Type 2 Inflammation in AERD. Journal of Allergy and Clinical Immunology, 148, 1157-1160. [Google Scholar] [CrossRef] [PubMed]
[11] Rusznak, M. and Peebles, R.S. (2019) Prostaglandin E2 in NSAID-Exacerbated Respiratory Disease: Protection against Cysteinyl Leukotrienes and Group 2 Innate Lymphoid Cells. Current Opinion in Allergy & Clinical Immunology, 19, 38-45. [Google Scholar] [CrossRef] 
[12] Cahill, K.N., et al. (2016) Impaired E Prostanoid2 Expres-sion and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease. American Journal of Respiratory Cell and Molecular Biology, 54, 34-40. [Google Scholar] [CrossRef] 
[13] 李化静, 刘立中. 阿司匹林三联征发病机制研究现状[J]. 国际耳鼻咽喉头颈外科杂志, 2012, 36(2): 68-72.
[14] Sousa, A.R., et al. (2002) Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive Rhinosinusitis. The New England Journal of Medicine, 347, 1493-1499. [Google Scholar] [CrossRef] 
[15] Lyly, A., Laidlaw, T.M. and Lundberg, M. (2021) Pathomechanisms of AERD-Recent Advances. Frontiers in Allergy, 2, Article ID: 734733. [Google Scholar] [CrossRef] [PubMed]
[16] James, A., et al. (2013) The Influence of Aspirin on Release of Eoxin C4, Leukotriene C4 and 15-HETE, in Eosinophilic Granulocytes Isolated from Patients with Asthma. International Archives of Allergy and Immunology, 162, 135-142. [Google Scholar] [CrossRef] [PubMed]
[17] Kristjansson, R.P., et al. (2019) A Loss-of-Function Variant in ALOX15 Protects against Nasal Polyps and Chronic Rhinosinusitis. Nature Genetics, 51, 267-276. [Google Scholar] [CrossRef] [PubMed]
[18] Imoto, Y., et al. (2020) Enhanced 15-Lipoxygenase 1 Production Is Related to Periostin Expression and Eosinophil Recruitment in Eosinophilic Chronic Rhinosinusitis. Biomolecules, 10, 1568. [Google Scholar] [CrossRef] [PubMed]
[19] Buchheit, K.M., et al. (2020) IL-5Ralpha Marks Nasal Polyp IgG4- and IgE-Expressing Cells in Aspirin-Exacerbated Respiratory Disease. Journal of Allergy and Clinical Immunol-ogy, 145, 1574-1584. [Google Scholar] [CrossRef] [PubMed]
[20] Gevaert, P., et al. (2020) Efficacy and Safety of Omalizumab in Na-sal Polyposis: 2 Randomized Phase 3 Trials. Journal of Allergy and Clinical Immunology, 146, 595-605. [Google Scholar] [CrossRef] [PubMed]
[21] Laidlaw, T.M., et al. (2019) Dupilumab Improves Nasal Polyp Burden and Asthma Control in Patients with CRSwNP and AERD. The Journal of Allergy and Clinical Immunology: In Practice, 7, 2462-2465.e1. [Google Scholar] [CrossRef] [PubMed]
[22] Cameli, P., et al. (2019) Omalizumab Treatment in Samter’s Triad: Case Series and Review of the Literature. European Review for Medical and Pharmacological Sciences, 23, 8124-8129.
[23] Lang, D.M., et al. (2018) Omalizumab Can Inhibit Respiratory Reaction during Aspirin Desensitiza-tion. Annals of Allergy, Asthma & Immunology, 121, 98-104. [Google Scholar] [CrossRef] [PubMed]
[24] Yang, R., et al. (2020) Acute Interstitial Nephritis: A Rare and Unusual Side Effect of Omalizumab. Journal of Investigative Medicine High Impact Case Reports, 8. [Google Scholar] [CrossRef] [PubMed]
[25] Yeung, W.Y.W. and Park, H.S. (2020) Update on the Management of Nonsteroidal Anti-Inflammatory Drug Hypersensitivity. Yonsei Medical Journal, 61, 4-14. [Google Scholar] [CrossRef] [PubMed]
[26] Santos, A.F., Alpan, O. and Hoffmann, H.J. (2021) Basophil Activation Test: Mechanisms and Considerations for Use in Clinical Trials and Clinical Practice. Allergy, 76, 2420-2432. [Google Scholar] [CrossRef] [PubMed]
[27] Novosad, J., et al. (2020) Serum Periostin Levels in Asthma Patients in Relation to Omalizumab Therapy and Presence of Chronic Rhinosinusitis with Nasal Polyps. Postȩpy Der-matologii i Alergologii, 37, 240-249. [Google Scholar] [CrossRef] [PubMed]
[28] Higashi, N., et al. (2004) Clinical Features of Asthmatic Patients with Increased Urinary Leukotriene E4 Excretion (Hyperleukotrienuria): Involvement of Chronic Hyperplastic Rhinosinusitis with Nasal Polyposis. Journal of Allergy and Clinical Immunology, 113, 277-283. [Google Scholar] [CrossRef] [PubMed]
[29] Taniguchi, M., et al. (2008) Hyperleukotrieneuria in Patients with Allergic and Inflammatory Disease. Allergology International, 57, 313-320. [Google Scholar] [CrossRef] 
[30] Divekar, R., et al. (2016) Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity. The Journal of Allergy and Clinical Immunology: In Practice, 4, 665-670. [Google Scholar] [CrossRef] [PubMed]

为你推荐